HER2 Support Group Forums - View Single Post - Drug Reimbursement Hotlines/Pre-Authorization Help

Lolly · 11-07-2005, 09:57 AM

Hi All; I found this website which may help some of you who are having difficulties/uncertainties regarding your insurance coverage of Herceptin for early stage disease. Good Luck!

Cancer Care Resources Drug Reimbursement Hotlines 2005
http://www.accc-cancer.org/ONCRES/on....asp#genentech

Genentech, Inc.
Genentech Reimbursement Hotline
Monday–Friday, 8 a.m.–5 p.m., PST
800.530.3083

Reimbursement specialists provide information, counseling, and hands-on assistance for problems with reimbursement for Genentech products: Activase® (alteplase, recombinant), Avastin™ (bevacizumab), Herceptin® (Trastuzamab), Nutropin® [somatropin (r DNA origin) for injection], Nutropin AQ® (somatrem for injection), Nutropin AQ Pen ™ Cartridge [somatropin (r DNA origin) injection], Rituxan ™ (Rituximab), Tarceva® (erlotinib). Information regarding Genentech Access to Care Foundation, established to provide medically indicated products to patients who are uninsured and have limited financial resources, is also provided.

Single Point of Contact (SPOC)
Monday–Friday, 6 a.m.–5 p.m. PST
Phone: 888.249.4918
Fax: 888.249.4919

Genentech BioOncology's SPOC provides timely, one-step reimbursement assistance. Oncology case managers will assist callers by: investigating benefits for new patients and those changing insurance or facing open enrollment, assisting with prior authorizations, helping with appeals and coverage denials, searching for alternative coverage for patients, answering questions related to product reimbursement, and consulting on coding/billing issues. Financial services include uninsured patient programs.

11-07-2005, 09:57 AM	#1
Lolly Senior Member Join Date: Aug 2001 Location: Oregon Posts: 1,756	Drug Reimbursement Hotlines/Pre-Authorization Help Hi All; I found this website which may help some of you who are having difficulties/uncertainties regarding your insurance coverage of Herceptin for early stage disease. Good Luck! Cancer Care Resources Drug Reimbursement Hotlines 2005 http://www.accc-cancer.org/ONCRES/on....asp#genentech Genentech, Inc. Genentech Reimbursement Hotline Monday–Friday, 8 a.m.–5 p.m., PST 800.530.3083 Reimbursement specialists provide information, counseling, and hands-on assistance for problems with reimbursement for Genentech products: Activase® (alteplase, recombinant), Avastin™ (bevacizumab), Herceptin® (Trastuzamab), Nutropin® [somatropin (r DNA origin) for injection], Nutropin AQ® (somatrem for injection), Nutropin AQ Pen ™ Cartridge [somatropin (r DNA origin) injection], Rituxan ™ (Rituximab), Tarceva® (erlotinib). Information regarding Genentech Access to Care Foundation, established to provide medically indicated products to patients who are uninsured and have limited financial resources, is also provided. Single Point of Contact (SPOC) Monday–Friday, 6 a.m.–5 p.m. PST Phone: 888.249.4918 Fax: 888.249.4919 Genentech BioOncology's SPOC provides timely, one-step reimbursement assistance. Oncology case managers will assist callers by: investigating benefits for new patients and those changing insurance or facing open enrollment, assisting with prior authorizations, helping with appeals and coverage denials, searching for alternative coverage for patients, answering questions related to product reimbursement, and consulting on coding/billing issues. Financial services include uninsured patient programs.